Skip to main content

CSH responds to NICE consultation on Cardiovascular disease: risk assessment and reduction

The National Institute of Health and Care Excellence (NICE) has been consulting on a draft guideline for cardiovascular disease risk assessment and reduction. The draft recommendations include prescribing statins to a much larger group of patients at a lower risk threshold than previously. CSH has responded to the consultation, welcoming the increased focus on prevention (which is the first principle of sustainable healthcare) but raising some concerns about the prioritisation of medication over lifestyle interventions.

Here are our key points:

Join the conversation and take action:

  1. Stay informed: Learn more about the NICE draft guideline and its potential impact on CVD risk assessment and reduction at https://www.nice.org.uk/guidance/indevelopment/gid-ng10178
  2. Join the conversation: Share your thoughts and opinions on the importance of lifestyle changes and sustainable healthcare on social media using the hashtag #CVDriskreduction, tagging @SusHealthcare, and linking to this post.
  3. Take action: Visit our website for more information and resources on sustainability in healthcare, and get involved by attending one of our courses in sustainability, health and healthcare.